Literature DB >> 18242093

Wilson's disease: a clinico-neuropathological autopsy study.

S Meenakshi-Sundaram1, A Mahadevan, A B Taly, G R Arunodaya, H S Swamy, S K Shankar.   

Abstract

Wilson's disease (WD), a familial neurological disorder involving the brain and liver secondary to altered copper metabolism, is common in South India. In view of the paucity of studies on this condition, the pathomorphological features of eight cases of WD were studied in detail at autopsy (brain alone, 1; brain and liver biopsy, 1; brain and visceral organs, 6), and are described with a discussion of the differential features of the neurological and hepatic forms. Of the six patients presenting with neurological manifestations, five had central pontine myelinolysis, five had subcortical white matter cavitations, four had putaminal softening, and six had variable ventricular dilatation, unlike the hepatic form. The presence of Opalski cells and pontine myelinolysis appear to be specific to the neurological form of WD. Liver abnormalities were observed in all cases (cirrhosis, 6; steatosis, 4; chronic active hepatitis, 2). Contrary to the rubric 'hepatolenticular degeneration', involvement of the lenticular nucleus was not universal, and nor was the pathology restricted to these anatomical areas.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18242093     DOI: 10.1016/j.jocn.2006.07.017

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  19 in total

Review 1.  Neurologic impairment in Wilson disease.

Authors:  Petr Dusek; Tomasz Litwin; Anna Członkowska
Journal:  Ann Transl Med       Date:  2019-04

Review 2.  Wilson disease.

Authors:  Anna Członkowska; Tomasz Litwin; Petr Dusek; Peter Ferenci; Svetlana Lutsenko; Valentina Medici; Janusz K Rybakowski; Karl Heinz Weiss; Michael L Schilsky
Journal:  Nat Rev Dis Primers       Date:  2018-09-06       Impact factor: 52.329

3.  Lenticular nucleus hyperechogenicity in Wilson's disease reflects local copper, but not iron accumulation.

Authors:  Uwe Walter; Marta Skowrońska; Tomasz Litwin; Grażyna Maria Szpak; Katarzyna Jabłonka-Salach; David Skoloudík; Ewa Bulska; Anna Członkowska
Journal:  J Neural Transm (Vienna)       Date:  2014-03-11       Impact factor: 3.575

4.  Liver cirrhosis in patients newly diagnosed with neurological phenotype of Wilson's disease.

Authors:  Adam Przybyłkowski; Grażyna Gromadzka; Grzegorz Chabik; Agata Wierzchowska; Tomasz Litwin; Anna Członkowska
Journal:  Funct Neurol       Date:  2014 Jan-Mar

5.  Diffusion tensor imaging (DTI) and its clinical correlates in drug naïve Wilson's disease.

Authors:  Rakesh Jadav; Jitender Saini; Sanjib Sinha; Bhavanishankara Bagepally; S Rao; Arun B Taly
Journal:  Metab Brain Dis       Date:  2013-05-01       Impact factor: 3.584

6.  Sleep in Wilson's disease: Questionnaire based study.

Authors:  Archana B Netto; Sanjib Sinha; Arun B Taly; Samhita Panda; Shivaji Rao
Journal:  Ann Indian Acad Neurol       Date:  2011-01       Impact factor: 1.383

7.  Wilson's disease: A Clinical autopsy case report with review of literature.

Authors:  Kalyani Raju; Gayathri Nagaraj Bangalore; Suresh Nagaraj Thuruvekere; Venkatarathnamma Narayanappa Pathavanalli
Journal:  J Nat Sci Biol Med       Date:  2015 Jan-Jun

Review 8.  Treatment strategies in Alzheimer's disease: a review with focus on selenium supplementation.

Authors:  Jan Aaseth; Jan Alexander; Geir Bjørklund; Knut Hestad; Petr Dusek; Per M Roos; Urban Alehagen
Journal:  Biometals       Date:  2016-08-16       Impact factor: 2.949

9.  Basal ganglia-orbitofrontal circuits are associated with prospective memory deficits in Wilson's disease.

Authors:  Sheng Hu; ChunSheng Xu; Yi Wang; Ting Dong; Hongli Wu; Anqin Wang; Chuanfu Li; BenSheng Qiu
Journal:  Brain Imaging Behav       Date:  2021-07-23       Impact factor: 3.978

10.  Neurochemical and behavioral characteristics of toxic milk mice: an animal model of Wilson's disease.

Authors:  Adam Przybyłkowski; Grażyna Gromadzka; Adriana Wawer; Ewa Bulska; Katarzyna Jabłonka-Salach; Tomasz Grygorowicz; Anna Schnejder-Pachołek; Andrzej Członkowski
Journal:  Neurochem Res       Date:  2013-07-23       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.